+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
BioMarin Pharmaceutical Inc. - logo

BioMarin is a world leader in developing and commercializing innovative biopharmaceuticals for rare diseases driven by genetic causes. They are leaders in metabolic disease innovation with multiple products commercialized and a pipeline of product candidates to address unmet medical needs. BioMarin's headquarters are based in Novato, California, United States.

From
Hematology Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Hematology Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 100 Pages
  • Global
From
Regenerative Medicine in Medical - Thematic Research - Product Thumbnail Image

Regenerative Medicine in Medical - Thematic Research

  • Report
  • July 2022
  • 40 Pages
  • Global
From
From
From
From
From
Erdheim Chester Disease Global Market Report 2024 - Product Thumbnail Image

Erdheim Chester Disease Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Rare Diseases Treatment Global Market Report 2024 - Product Thumbnail Image

Rare Diseases Treatment Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
From
Viral Gastroenteritis Global Market Report 2024 - Product Thumbnail Image

Viral Gastroenteritis Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Hemophilia Drugs - Global Strategic Business Report - Product Thumbnail Image

Hemophilia Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 182 Pages
  • Global
From
From
Chronic Disease Markets for Sustained Released Injectables - Product Thumbnail Image

Chronic Disease Markets for Sustained Released Injectables

  • Report
  • December 2023
  • 217 Pages
  • Global
From
Gene Therapy Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Gene Therapy Collaboration and Licensing Deals 2016-2024

  • Report
  • November 2024
  • 450 Pages
  • Global
From
Extended Release Injectable Drugs - Product Thumbnail Image

Extended Release Injectable Drugs

  • Report
  • June 2023
  • 200 Pages
  • Global
From
Loading Indicator